Doctor Paul Sugarbaker, MD, FACS, FRCS Profile

Paul Sugarbaker, MD, FACS, FRCS: Gastrointestinal Oncology
Average Rating:
Address:110 Irving Street, NW Washington, DC, , washington-dc USA - United States of America, 20010
Email: Paul.Sugarbaker@medstar.net
Phone: (202) 877-3908
Treatment Center: Washington Cancer Institute

Dr. Paul h. Sugarbaker, MD, FACS, FRCS is an expert in the treatment of peritoneal mesothelioma by combining cytoreductive surgery with intraperitoneal and systemic chemotherapy. He attained his B.S. from Wheaton College, Wheaton, Illinois.

He went on to earn his Medical Degree at Cornell University Medical College in New York, New York. He received M.D. with honors, from Cornell University Medical College. He completed surgical fellowship at Massachusetts General Hospital in Boston, Massachusetts. He also achieved M.A. degree in Immunology from the Graduate School of Arts and Sciences at Harvard University in Cambridge, Massachusetts. Dr. Sugarbaker underwent Surgical Internship and also completed his Surgical Residency, at Peter Brigham Hospital in Boston. He is board certified by the American Board of Surgery.

Dr. Sugarbaker was the Surgical Chief Resident at Peter Bent Brigham Hospital and he spent the next three years as a Research Trainee at the Massachusetts General Hospital, Boston, Massachusetts. Later on he became the Senior Investigator at the Surgery Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Maryland and also the Head of the Colorectal Cancer Section, Surgery Branch, at the National Cancer Institute, National Institutes of Health in Bethesda, Maryland. He appointed as the Director of Surgical Oncology at Emory University School of Medicine in Atlanta, Georgia; Medical Director at Washington Cancer Institute at Washington Hospital Center in Washington, DC and his current position, Director of Surgical Oncology at Washington Cancer Institute in Washington, DC.

Dr. Sugarbaker is the author of many books, scientific articles and reports. He is the setting up member of the International Society of Regional Cancer Therapy (ISRCT) and also an active member of the Editorial Board of the European Journal of Surgical Oncology.